Cephalosporins

3,145 views 29 slides Jul 15, 2020
Slide 1
Slide 1 of 29
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29

About This Presentation

Pharmacology of cephalosporins, monobactums and carbapenums including their mechanism of action, indications, adverse effects.
The various generations of cephalosporins and their spectrum of action


Slide Content

Cephalosporins Dr Naser Ashraf Tadvi Associate Professor Department of Pharmacology Ayaan Institute of Medical Sciences

Cephalosporins The cephalosporins are β -Lactam antibiotics closely structurally and functionally to the penicillins . Mechanism of action, mechanism of resistance and some other properties of cephalosporins are identical to penicillins ) Cephalosporins are one of the most widely used antibiotics and are equal in importance to penicillin.

History of cephalosporins In 1945 Giuseppe Brotzu`s discovered that cultures of Cephalosporium acremonium inhibited the growth of a wide variety of Gram-positive and Gram-negative bacteria.

Structure of Cephalosporins

Mechanism of action of Cephalosporins cephalosporins Bind & inactivate CBP on cell wall of susceptible bacteria Inhibit transpeptidase Autolysis & cell death Prevent peptidoglycan synthesis Cell wall deficient forms

Mechanisms of resistance Alteration of binding site. Decrease permeability. Production of β–lactamase enzymes (enzymatic inactivation)

Classification of CEPHALOSPORINS First generation Second generation Third generation Fourth generation Fifth Generation Parenteral Cephalothin Cefazolin Cefuroxime Cefoxitin Cefotaxime Ceftriaxone Cefoperazone Ceftazidime Ceftizoxime Cefepime Cefpirome Ceftaroline Ceftobirole Oral Cephalexin Cephradine Cefadroxil Cefaclor Cefuroxime axetil Cefprozil Cefixime Cefpodoxime Cefdinir Ceftibuten - -

First Generation cephalosporins (Spectrum of action) +Cocci - Bacilli > Streptococci Pneumococci MSSA P roteus Ec oli K lebsiella Peptococci

Pharmacokinetics Oral cephalosporins are well absorbed Do not cross BBB Primarily excreted by the kidney Probenecid prolongs their half life All administered 6-8 hourly except cefadroxil which is administered 12 hourly

Indications / uses Not used for serious infections and ineffective in meningitis Minor staphylococcal infections Infections like cellulitis and soft tissue abscess Cefazolin has better penetration to tissues hence is drug of choice for surgical prophylaxis before cardiac surgery and orthopedic prosthesis procedures

Second generation cephalosporins Oral Cefaclor Cefuroxime axetil Cefprozil Parenteral Cefuroxime Cefotetan Cefamandole Cefoxitin

Second Generation cephalosporins (Spectrum of action) +Cocci - Bacilli - Cocci > Extended Gram - ve coverage H Influenzae N. Gonorrhoeae P roteus E c oli K lebsiella Less active against gram positive cocci and bacilli than 1 st Generation S pneumoniae S Pyogenes

Pharmacokinetics cefaclor, cefprozil , cefuroxime axetil good oral bioavailability Only cefuroxime crosses BBB & achieves therapeutic concentration in CSF More stable to beta lactamases except cefaclor Intramuscular injections are painful Excreted unchanged in Kidney

Indications/ Uses Cefoxitin & Cefotetan have good anaerobic activity used in anaerobic infections like peritonitis, diverticulitis, gynecological infections Cefaclor & cefprozil used to treat respiratory tract infections Cefuroxime used in community acquired pneumonia, single dose therapy iv for PPNG Gonorrhoea , meningitis – third generation cephalosporins preferred cefamandole preferred for treating sexually transmitted diseases

Third Generation cephalosporins Oral Cefixime Cefpodoxime Cefdinir Ceftibuten Ceftolazone Parenteral Cefotaxime Ceftriaxone Cefoperazone Ceftazidime Ceftizoxime

Third Generation cephalosporins (Spectrum of action) +Cocci - Bacilli + Bacilli - Cocci > Highly effective H Influenzae Enterobacter N. Gonorrhoeae, Meningitis P roteus E c oli K lebsiella S erratia Less active against gram positive cocci than 1 st Generation Anaerobes Cefoperazone and Ceftazidime effective against Pseudomonas

Pharmacokinetics All can cross BBB Ceftriaxone has t½ : 7-8 hours and high plasma protein binding 90% Cefotaxime metabolized to active metabolite Cefoperazone and ceftriaxone excreted through bile All others major route of excretion is urinary

Indications/ Uses Serious infections caused by: Klebsiella , Enterobacter, Proteus , Haemophilus species. Gonorrhoea : Ceftriaxone DOC for all forms Meningitis : Cefotaxime= 1gm 6- 12 hrly , ceftriaxone = 4 gm then 2 gm IV daily OD for 7to 10 days Ceftazidime + aminoglycoside is the drug of choice for Pseudomonas meningitis UTI: Cefixime, Cefpodoxime 200- 400 mg BD

Indications/ uses Respiratory tract infections: Community acquired pneumonia, chronic bronchitis, otitis media, sinusitis, pharyngitis . Typhoid: ceftriaxone 4 gm IV daily for 2 days then 2 gm daily till fever subsides Oral cefixime 200 mg BD

Fourth generation cephalosporins cefipime , cefpirome, cefozopran

Fifth generation cephalosporins Ceftaroline , ceftobiprole Bind to and inhibit altered PBP 2a Produced by MRSA and penicillin resistant Streptococcus Pneumoniae Retain spectrum of 4 th generation cephalosporins and notable increase in activity against gram positive cocci ( MRSA, streptococcus pneumoniae and pyogenes, enterococcus) Limited activity against anaerobes

S p e c t r um c e p h a l o s p o r i n s I Generation Gm - ve PEcK Gm + ve HENPEcK HENPEcK Enterobacteraciae,bact . Fragilis , pseudomonas I I Generation I I I Generation IV Generation Also against serratia , acinebacter V Generation MRSA, S. Pneumoniae

Adverse Effects Allergic and hypersensitivity reactions Disulfiram-like effect: cefamandole, cefaperazone Bleeding: cefamandole, & cefoperazone Nephrotoxicity: Cephalothine Ceftriaxone: pseudolithiasis Neutropenia & thrombocytopenia: ceftazidime Superinfection, pseudomembranous enterocolitis and diarrhoea : Pain at the injection site

Other B- Lactum antibiotics Monobactums : Aztreonam Monocyclic Low affinity for PBP OF Staph, strepto & anaerobes Spectrum: Aerobic Gm – ve , enteric bacilli & H- influenzae at low conc. Pseudomonas at moderate conc Klebsiella , proteus , citrobacter , yersinia , salmonella, shigella , serratia , & neisseria Resistant to Gm – ve B-lactamases

Aztreonam: continued Uses: Gm – ve infections where aminoglycosides are to be avoided Hospital acquired infections: urinary, biliary , GIT, female genital tract Promising feature: Lack of cross sensitivity to other B- Lactum antibiotics Pharmacokinetics: Not bioavailable , IM/IV Mainly excreted by kidneys 60 – 70 % Side effects: Diarrhoea , skin rash, pain

Carbapenems Imipenem Broad spectrum beta lactum effective against Gm + cocci, enterobacteraciae , pseudomonas, listeria, Bacteroides , cl difficle Rapid hydrolysis by dehydropeptidase I Can be combined with cilastatin , a reversible inhibitor of dehydropeptidase - I Dose: 0.5 gm iv 6 hrly max 4 gm/day Can cause seizures in high doses

Carbapenems Meropenem Not hydrolysed by dehydropeptidase Effective against both Gm + & Gm – bacteria, Aerobes as well as anaerobes Reserve drug for treatment of serious nosocomial infections like septicaemia , febrile neutropenia Cephalosporin resistant Intra-abdominal and pelvic infections With aminoglycosides for pseudomonas infection Dose: 0.5 – 2 gm slow IV 8 hrly

Faropenem Orally active against many Gm + & Gm – bacteria including some anaerobes Used mainly in respiratory tract infections Strep pneumoniae , H influenzae , moraxella ENT, genitourinary infections Dose: 200 -300 mg oral TDS

Other antibiotics inhibiting cell wall synthesis Vancomycin , teicoplanin (Glycopeptides) Daptomycin ( lipopeptide ) Bacitracin ( polypeptide) Fosfomycin & cycloserine (D- alanine analog)